Finance Watch: Cell And Gene Therapy Firms Raised Nearly $20bn In 2020
Annual ARM Report Shows $19.9bn Raised Globally, A New Record
Private Company Edition: Venture capital mega-rounds continue a brisk pace with machine learning-based drug discovery firm insitro and gene therapy developer Graphite Bio among recent $100m-plus deals. Also, Argobio raised €50m to fund five start-ups in Europe.
